Sickle Cell Disease - Epidemiology Insights to 2025

July 2017 | 40 pages | ID: S1F7B1A3FD0EN
DelveInsight

Abstracts

This report can be delivered to the clients within 5-7 Business Days

DelveInsight’s “Sickle Cell Disease -Epidemiology Forecast, 2025” provides an overview of the epidemiology trends of Sickle Cell Disease in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Sickle Cell Disease. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical needs associated with the Sickle Cell Disease. The report contains the targeted patient populations and the forecast methodology.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by DelveInsight team of industry experts.

Key Coverage and Benefits

• The Report includes the prevalent population and how will it change over the next eight years.
• Coverage of key Sickle Cell Disease sub-populations and its prevalent or incident cases
• Prevalent or incident cases segmented by age and sex.
• The key differences in epidemiology patterns across the seven market segments.

Reasons to buy

• Developing business strategies by understanding the trends shaping and driving the global Sickle Cell Disease market.
• Identifying prevalent patient populations as well as risk factors in the global Sickle Cell Disease market will help to improve product design, pricing, and launch plans.
• Organize sales and marketing efforts by identifying the best opportunities for Sickle Cell Disease therapeutics in each of the markets covered.

Contents

1. REPORT INTRODUCTION

2. SNAPSHOT OF TOTAL PREVALENT OR INCIDENT CASES BY 7 MM

3. EXECUTIVE SUMMARY

  Key Findings

4. SICKLE CELL DISEASE OVERVIEW

  Sickle Cell Disease Definition
  Pathophysiology
  Symptoms
  Etiology

5. RISK FACTORS ASSOCIATED WITH SICKLE CELL DISEASE

6. DISEASE BURDEN & UNMET NEED IN THE MARKET

7. EPIDEMIOLOGY AND PATIENT POPULATIONS

  Key Findings
  Key Sources used and Forecast Methodology
  Prevalent Cases and Incident Cases-2015-2025
  Prevalent & Incident Cases by Category-2015-2025
  Age-Specific Prevalent/ Incident Cases of Sickle Cell Disease
  Sex-Specific Prevalent/Incident Cases of Sickle Cell Disease
  Disease Type Specific Prevalent/Incident Cases of Sickle Cell Disease

8.PREVALENT & INCIDENT CASES BY 7 MM-2015-2025

  Sickle Cell Disease Epidemiology of United States-2025
  Sickle Cell Disease Epidemiology of United Kingdom-2025
  Sickle Cell Disease Epidemiology of Germany-2025
  Sickle Cell Disease Epidemiology of France-2025
  Sickle Cell Disease Epidemiology of Spain-2025
  Sickle Cell Disease Epidemiology of Italy-2025
  Sickle Cell Disease Epidemiology of Japan-2025

9. KEY TAKEAWAYS

10. APPENDIX

11.REPORT METHODOLOGY

12. CONSULTING SERVICES

13. DISCLAIMER

14. ABOUT US

List Of Tables

LIST OF TABLES

Table 1: Clinical subtypes of Indication
Table 2: Risk Factors
Table 3: Prevalence cases (%) Region wise
Table 4: Sources used for forecasting the data
Table 5: Sickle Cell Disease Global Epidemiology, (2015-2025)
Table 6: Prevalent Cases of Sickle Cell Disease (Ages =XX Years), US (2015-2025)
Table 7: Prevalent Cases of Sickle Cell Disease By Sex (Males & Females), US (2015-2025)
Table 8: Prevalent Cases By Sickle Cell Disease Sub-population, US (2015-2025)
Table 9: Prevalent Cases of Sickle Cell Disease (Ages =XX Years), United Kingdom (2015-2025)
Table 10: Prevalent Cases of Sickle Cell Disease By Sex (Males & Females), United Kingdom (2015-2025)
Table 11: Prevalent Cases By Sickle Cell Disease Sub-population, United Kingdom (2015-2025)
Table 12: Prevalent Cases of Sickle Cell Disease (Ages =XX Years), Germany (2015-2025)
Table 13: Prevalent Cases of Sickle Cell Disease By Sex (Males & Females), Germany (2015-2025)
Table 14: Prevalent Cases By Sickle Cell Disease Sub-population, Germany (2015-2025)
Table 15: Prevalent Cases of Sickle Cell Disease (Ages =XX Years), France (2015-2025)
Table 16: Prevalent Cases of Sickle Cell Disease By Sex (Males & Females), France (2015-2025)
Table 17: Prevalent Cases By Sickle Cell Disease Sub-population, France (2015-2025)
Table 18: Prevalent Cases of Sickle Cell Disease (Ages =XX Years), Italy (2015-2025)
Table 19: Prevalent Cases of Sickle Cell Disease By Sex (Males & Females), Italy (2015-2025)
Table 20: Prevalent Cases By Sickle Cell Disease Sub-population, Italy (2015-2025)
Table 21: Prevalent Cases of Sickle Cell Disease (Ages =XX Years), Spain (2015-2025)
Table 22: Prevalent Cases of Sickle Cell Disease By Sex (Males & Females), Spain (2015-2025)
Table 23: Prevalent Cases By Sickle Cell Disease Sub-population, Spain (2015-2025)
Table 24: Prevalent Cases of Sickle Cell Disease (Ages =XX Years), Japan (2015-2025)
Table 25: Prevalent Cases of Sickle Cell Disease By Sex (Males & Females), Japan (2015-2025)
Table 26: Prevalent Cases By Sickle Cell Disease Sub-population, Japan (2015-2025)

List Of Figures

LIST OF FIGURES

Figure 1: Prevalence cases (%) Region wise
Figure 2: Sources used for forecasting the data
Figure 3: Sickle Cell Disease Global Epidemiology, (2015-2025)
Figure 4: Prevalent Cases of Sickle Cell Disease (Ages =XX Years), US (2015-2025)
Figure 5: Prevalent Cases of Sickle Cell Disease By Sex (Males & Females), US (2015-2025)
Figure 6: Prevalent Cases By Sickle Cell Disease Sub-population,US (2015-2025)
Figure 7: Prevalent Cases of Sickle Cell Disease (Ages =XX Years), United Kingdom (2015-2025)
Figure 8: Prevalent Cases of Sickle Cell Disease By Sex (Males & Females), United Kingdom (2015-2025)
Figure 9: Prevalent Cases By Sickle Cell Disease Sub-population,United Kingdom (2015-2025)
Figure 10: Prevalent Cases of Sickle Cell Disease (Ages =XX Years), Germany (2015-2025)
Figure 11: Prevalent Cases of Sickle Cell Disease By Sex (Males & Females), Germany (2015-2025)
Figure 12: Prevalent Cases By Sickle Cell Disease Sub-population,Germany (2015-2025)
Figure 13: Prevalent Cases of Sickle Cell Disease (Ages =XX Years), France (2015-2025)
Figure 14: Prevalent Cases of Sickle Cell Disease By Sex (Males & Females), France (2015-2025)
Figure 15: Prevalent Cases By Sickle Cell Disease Sub-population,France (2015-2025)
Figure 16: Prevalent Cases of Sickle Cell Disease (Ages =XX Years), Italy (2015-2025)
Figure 17: Prevalent Cases of Sickle Cell Disease By Sex (Males & Females), Italy (2015-2025)
Figure 18: Prevalent Cases By Sickle Cell Disease Sub-population,Italy (2015-2025)
Figure 19: Prevalent Cases of Sickle Cell Disease (Ages =XX Years), Spain (2015-2025)
Figure 20: Prevalent Cases of Sickle Cell Disease By Sex (Males & Females), Spain (2015-2025)
Figure 21: Prevalent Cases By Sickle Cell Disease Sub-population,Spain (2015-2025)
Figure 22: Prevalent Cases of Sickle Cell Disease (Ages =XX Years), Japan (2015-2025)
Figure 23: Prevalent Cases of Sickle Cell Disease By Sex (Males & Females), Japan (2015-2025)
Figure 24: Prevalent Cases By Sickle Cell Disease Sub-population,Japan (2015-2025)